Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 16;46(1):84.
doi: 10.1186/s13052-020-00843-2.

Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic

Collaborators, Affiliations
Review

Consensus statement of the Italian society of pediatric allergy and immunology for the pragmatic management of children and adolescents with allergic or immunological diseases during the COVID-19 pandemic

Fabio Cardinale et al. Ital J Pediatr. .

Abstract

The COVID-19 pandemic has surprised the entire population. The world has had to face an unprecedented pandemic. Only, Spanish flu had similar disastrous consequences. As a result, drastic measures (lockdown) have been adopted worldwide. Healthcare service has been overwhelmed by the extraordinary influx of patients, often requiring high intensity of care. Mortality has been associated with severe comorbidities, including chronic diseases. Patients with frailty were, therefore, the victim of the SARS-COV-2 infection. Allergy and asthma are the most prevalent chronic disorders in children and adolescents, so they need careful attention and, if necessary, an adaptation of their regular treatment plans. Fortunately, at present, young people are less suffering from COVID-19, both as incidence and severity. However, any age, including infancy, could be affected by the pandemic.Based on this background, the Italian Society of Pediatric Allergy and Immunology has felt it necessary to provide a Consensus Statement. This expert panel consensus document offers a rationale to help guide decision-making in the management of children and adolescents with allergic or immunologic diseases.

Keywords: Adolescent; Allergy; Asthma; COVID-19; Child; Immunologic disease; Pandemic.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Bousquet J, Akdis C, Jutel M, et al. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: an ARIA-EAACI statement. Allergy. 2020; (in press). - PubMed
    1. Shaker MS, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh EWY, et al. COVID-19: Pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract. 2020; (in press). - PMC - PubMed
    1. Corsico A, Leonardi S, Licari A, Marseglia GL. Miraglia del Giudice M, Peroni D, et al. focus on the cetirizine use in clinical practice: a reappraisal 30 years later. Multidisciplinary. Respir Med. 2019;14:40. - PMC - PubMed
    1. Parisi G, Leonardi S, Ciprandi G, Corsico A, Licari A, Miraglia del Giudice M, et al. Antihistamines in children and adolescents: a practical update. Allergol Immunopathol. 2020; (in press). - PubMed
    1. Ciprandi G, Cosentino C, Milanese M, Mondino C, Canonica GW. Fexofenadine treatment reduces nasal congestion in allergic rhinitis. Allergy. 2001;56:1068–1070. doi: 10.1034/j.1398-9995.2001.00191.x. - DOI - PubMed